Targeted Proteomics to Assess the Response to Anti-Angiogenic Treatment in Human Glioblastoma (GBM)

Glioblastoma (GBM) is a highly aggressive primary brain tumor with dismal outcome for affected patients. Because of the significant neo-angiogenesis exhibited by GBMs, anti-angiogenic therapies have been intensively evaluated during the past years. Recent clinical studies were however disappointing,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Cell Proteomics
Autors principals: Demeure, Kevin, Fack, Fred, Duriez, Elodie, Tiemann, Katja, Bernard, Amandine, Golebiewska, Anna, Bougnaud, Sébastien, Bjerkvig, Rolf, Domon, Bruno, Niclou, Simone P.
Format: Artigo
Idioma:Inglês
Publicat: The American Society for Biochemistry and Molecular Biology 2016
Matèries:
Special Issue Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4739668/
https://ncbi.nlm.nih.gov/pubmed/26243272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/mcp.M115.052423
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars